News
A promising new cancer technology from NIH could help improve how liver cancer is diagnosed and treated. Liver cancer, particularly hepatocellular carcinoma (HCC), remains one of the deadliest cancers worldwide, and better treatment options are urgently needed. NIH inventors have developed two fully
NIH is seeking a licensee or collaborator for Nipamovir, an affordable oral treatment for HIV infection with a high barrier to resistance. Nipamovir is a low molecular weight mercaptobenzamide derivative that is simple to produce and can be used to lower or eliminate the infectivity of HIV. It
NIH inventors are seeking a licensee or collaborator for a micro-engineered “thyroid-on-a-chip” that combines human thyroid organoids with integrated micro-vasculature to replicate the gland’s native blood flow and 3-D architecture, enabling rapid, patient-specific drug screening. This technology
Inventors at the NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) are seeking a licensee or collaborator for positive allosteric modulators (PAMs) of the A 3 adenosine receptor (A 3AR), a known therapeutic target. These heterocyclic chemical compounds bind to a lipid